These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29577987)

  • 1. Generalized pruritus relieved by NSAIDs in the setting of mast cell activation syndrome.
    Kesterson K; Nahmias Z; Brestoff JR; Bodet ND; Kau A; Kim BS
    J Allergy Clin Immunol Pract; 2018; 6(6):2130-2131. PubMed ID: 29577987
    [No Abstract]   [Full Text] [Related]  

  • 2. Mast Cell Activation Syndrome.
    Frieri M
    Clin Rev Allergy Immunol; 2018 Jun; 54(3):353-365. PubMed ID: 25944644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mast cell disorders: Protean manifestations and treatment responses.
    Chen M; Kim A; Zuraw B; Doherty TA; Christiansen S
    Ann Allergy Asthma Immunol; 2018 Jul; 121(1):128-130. PubMed ID: 29604336
    [No Abstract]   [Full Text] [Related]  

  • 4. Syncope as a manifestation of mast cell activation disorder.
    Perales Chordá C; Fabregat Nebot S; Moral Moral P; Jarque Ramos I; Hernández Fernandez de Rojas D
    Ann Allergy Asthma Immunol; 2015 Feb; 114(2):153-4. PubMed ID: 25624133
    [No Abstract]   [Full Text] [Related]  

  • 5. Developing a standardized approach for assessing mast cells and eosinophils on tissue biopsies: A Work Group Report of the AAAAI Allergic Skin Diseases Committee.
    Zimmermann N; Abonia JP; Dreskin SC; Akin C; Bolton S; Happel CS; Geller M; Larenas-Linnemann D; Nanda A; Peterson K; Wasan A; Wechsler J; Zhang S; Bernstein JA
    J Allergy Clin Immunol; 2021 Oct; 148(4):964-983. PubMed ID: 34384610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast cell disorders and idiopathic anaphylaxis: Evaluation and management.
    Khalid MB; Lieberman P
    Allergy Asthma Proc; 2020 Mar; 41(2):90-98. PubMed ID: 32122445
    [No Abstract]   [Full Text] [Related]  

  • 7. NSAID Hypersensitivity.
    Sánchez-Borges M; Park HS
    J Allergy Clin Immunol Pract; 2019 Feb; 7(2):746-747. PubMed ID: 30717875
    [No Abstract]   [Full Text] [Related]  

  • 8. New Insights into Clonal Mast Cell Disorders Including Mastocytosis.
    Volertas S; Schuler CF; Akin C
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):341-350. PubMed ID: 30007455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hymenoptera Allergy and Mast Cell Activation Syndromes.
    Bonadonna P; Bonifacio M; Lombardo C; Zanotti R
    Curr Allergy Asthma Rep; 2016 Jan; 16(1):5. PubMed ID: 26714690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Mast Cells in the Pathogenesis of Pruritus in Mastocytosis.
    Kwiatkowska D; Reich A
    Acta Derm Venereol; 2021 Oct; 101(10):adv00583. PubMed ID: 34642766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast Cell Activation Syndrome and Mastocytosis: Initial Treatment Options and Long-Term Management.
    Castells M; Butterfield J
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1097-1106. PubMed ID: 30961835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast cell activation syndrome: improved identification by combined determinations of serum tryptase and 24-hour urine 11β-prostaglandin2α.
    Ravi A; Butterfield J; Weiler CR
    J Allergy Clin Immunol Pract; 2014; 2(6):775-8. PubMed ID: 25439370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic criteria and classification of mastocytosis in 2014.
    Akin C; Valent P
    Immunol Allergy Clin North Am; 2014 May; 34(2):207-18. PubMed ID: 24745670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical diagnosis of systemic mast cell disorders.
    Roberts LJ; Oates JA
    J Invest Dermatol; 1991 Mar; 96(3 Suppl):19S-24S; discussion 24S-25S; 60S-65S. PubMed ID: 16799604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast cell activation in Dowling-Degos disease.
    Knuever J; Persa OD; Illerhaus A; Ralser DJ; Hartmann K; Betz RC; Tantcheva-Poór I
    Br J Dermatol; 2019 Dec; 181(6):1312-1314. PubMed ID: 31206596
    [No Abstract]   [Full Text] [Related]  

  • 16. Mast cell activation syndrome: a review.
    Frieri M; Patel R; Celestin J
    Curr Allergy Asthma Rep; 2013 Feb; 13(1):27-32. PubMed ID: 23179866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and laboratory parameters of mast cell activation as basis for the formulation of diagnostic criteria.
    Valent P; Horny HP; Triggiani M; Arock M
    Int Arch Allergy Immunol; 2011; 156(2):119-27. PubMed ID: 21576982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptoms of mast cell activation: The patient perspective.
    Jennings SV; Slee VM; Finnerty CC; Hempstead JB; Bowman AS
    Ann Allergy Asthma Immunol; 2021 Oct; 127(4):407-409. PubMed ID: 34271184
    [No Abstract]   [Full Text] [Related]  

  • 19. Anaphylactic Reactions After Discontinuation of Hymenoptera Venom Immunotherapy: A Clonal Mast Cell Disorder Should Be Suspected.
    Bonadonna P; Zanotti R; Pagani M; Bonifacio M; Scaffidi L; Olivieri E; Franchini M; Reccardini F; Costantino MT; Roncallo C; Mauro M; Boni E; Rizzini FL; Bilò MB; Marcarelli AR; Passalacqua G
    J Allergy Clin Immunol Pract; 2018; 6(4):1368-1372. PubMed ID: 29258788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From "Samter's Triad" to "NERD": The Long and Winding Road to Understanding Aspirin-Exacerbated Respiratory Disease.
    Tilles SA
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):xiii-xiv. PubMed ID: 27712770
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.